IP Library Granted Patent US 9,085,585
Granted Patent B2
US 9,085,585 · App. 13/673,799 · Granted Jul 21, 2015

Compounds, compositions and methods useful for cholesterol mobilization

Inventors: Daniela Carmen Oniciu (Toulouse, FR); Jean-Louis Henri Dasseux (Toulouse, FR); Otto Geoffroy (Gainesville, FL); Ronald Barbaras (Seilh, FR)
Assignee: Cerenis Therapeutics Holding SA
C07D493/04A61K31/155A61K31/194A61K31/198A61K31/20A61K31/201A61K31/353A61K31/4365A61K31/5377A61K31/575A61K31/7032C07D401/04C07D401/14C07D471/04C07D495/04C07D513/04G01N33/92G01N2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,085,585
App. No.
13/673,799
Granted
Jul 21, 2015
Kind
B2
Abstract

The invention relates to classes of pharmaceutically-active heterocyclic compounds and pharmaceutically acceptable salts, and hydrates thereof, and compositions comprising the same. The invention also relates to methods for treating or preventing a disease or disorder, which comprises administering a therapeutically or prophylactically effective amount a compound described herein.

Claims (22)

1. A compound of Formula (I):

or a pharmaceutically acceptable salt thereof, wherein

each of R 1 , R 2 , and R 3 is independently —H, —OH, —NH 2 , —NH(alkyl), —N(alkyl)(alkyl), hydrocarbyl, —O-hydrocarbyl, aryl, —O-aryl, aralkyl, —O-aralkyl, heteroaryl, —O-heteroaryl, heterocyclyl, —O-heterocyclyl, halo, —OCF 3 , —C(O)O(alkyl), —OC(O)(alkyl), —C(O)NH 2 , —C(O)NH(alkyl), —C(O)N(alkyl)(alkyl), —NHC(O)(alkyl), —N(alkyl)C(O)(alkyl), —OC(O)O(alkyl), —OC(O)NH 2 , —OC(O)NH(alkyl), —OC(O)N(alkyl)(alkyl), —CHNH, —CHN(alkyl), or —SO 2 NH 2 ;

R 4 is —OH, —COOH, or —C(O)O(alkyl),

Z 1 is S;

Z 2 is N; and

n is an integer from 1-6.

2. The compound or pharmaceutically acceptable salt of the compound of claim 1 , wherein R 1 is 2-halo.

3. The compound or pharmaceutically acceptable salt of claim 2 , wherein each of R 2 and R 3 is independently —H or alkyl.

4. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt of any of the foregoing.

5. A composition comprising an effective amount of a compound or pharmaceutically acceptable salt of the compound of claim 1 and

a pharmaceutically acceptable vehicle or carrier.

6. The composition of claim 5 , wherein the composition is formulated for oral administration.

7. The composition of claim 5 , wherein the composition is in the form of a tablet or capsule.

8. The composition of claim 5 , wherein the compound or salt thereof is present in an amount of about 1 mg to about 1,000 mg.

9. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

10. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

11. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

Assignments (5)
CHANGE OF ADDRESS FOR REEL/FRAME 029616/0015 Recorded Dec 26, 2018
From: CERENIS THERAPEUTICS HOLDING SA
To: CERENIS THERAPEUTICS HOLDING SA
Reel/Frame 049149/0099 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2013
From: ONICIU, DANIELA CARMEN; DASSEUX, JEAN-LOUIS HENRI; BARBARAS, RONALD
To: CERENIS THERAPEUTICS SA
Reel/Frame 029615/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2013
From: GEOFFROY, OTTO
To: ALCHEM LABORATORIES CORP.
Reel/Frame 029615/0993 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2013
From: ALCHEM LABORATORIES CORP.
To: CERENIS THERAPEUTICS SA
Reel/Frame 029616/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2013
From: CERENIS THERAPEUTICS SA
To: CERENIS THERAPEUTICS HOLDING SA
Reel/Frame 029616/0015 →
Continuity (4)
Division 13276238 · Oct 18, 2011
Provisional Application 61394136 · Oct 18, 2010
Provisional Application 61444212 · Feb 18, 2011
Related Publication 20130267554A1 · Oct 10, 2013